Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yung-Sung Yeh, Hsiang-Lin Tsai, Po-Jung Chen, Yen-Cheng Chen, Wei-Chih Su, Tsung-Kun Chang, Ching-Wen Huang & Jaw-Yuan Wang. (2023) Identifying and clinically validating biomarkers for immunotherapy in colorectal cancer. Expert Review of Molecular Diagnostics 23:3, pages 231-241.
Read now
Read now
Hongchi Wang, Bin Ma, Peng Gao, Yongxi Song, Qingzhou Xu, Yaoyuan Hu, Cong Zhang & Zhenning Wang. (2016) Efficacy and safety of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer in first-line and second-line therapies: a meta-analysis. OncoTargets and Therapy 9, pages 5405-5416.
Read now
Read now
Articles from other publishers (18)
Yuliya Kitsel, Timothy Cooke, Vlasios Sotirchos & Constantinos T. Sofocleous. (2023) Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies. Cancers 15:6, pages 1679.
Crossref
Crossref
Jeong-Ki Park, Min-Jae Yoo, Hyuk Jang, Sang-Youel Park, Jawun Choi & Jae-Won Seol. (2022) Methyl Gallate Suppresses Tumor Development by Increasing Activation of Caspase3 and Disrupting Tumor Angiogenesis in Melanoma. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-13.
Crossref
Crossref
Lindsey Carlsen, Kelsey E. Huntington & Wafik S. El-Deiry. (2022) Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. Cancers 14:4, pages 1028.
Crossref
Crossref
Lin Wang, Yi-Fan Lu, Chao-Shan Wang, Yun-Xia Xie, Yan-Qiu Zhao, Ying-Chen Qian, Wei-Tao Liu, Min Wang & Bing-Hua Jiang. (2020) HB-EGF Activates the EGFR/HIF-1α Pathway to Induce Proliferation of Arsenic-Transformed Cells and Tumor Growth. Frontiers in Oncology 10.
Crossref
Crossref
Tania Crombet Ramos, Braulio Mestre Fernández, Zaima Mazorra Herrera & Normando E. Iznaga Escobar. (2020) Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck. Frontiers in Oncology 10.
Crossref
Crossref
Martin D. Berger, Yan Ning, Sebastian Stintzing, Volker Heinemann, Shu Cao, Wu Zhang, Dongyun Yang, Yuji Miyamoto, Mitsukuni Suenaga, Marta Schirripa, Diana L. Hanna, Shivani Soni, Alberto Puccini, Ryuma Tokunaga, Madiha Naseem, Francesca Battaglin, Chiara Cremolini, Alfredo Falcone, Fotios Loupakis & Heinz-Josef Lenz. (2020) A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials. European Journal of Cancer 131, pages 89-97.
Crossref
Crossref
Maria Latacz, Jadwiga Snarska, Elżbieta Kostyra, Ewa Fiedorowicz, Huub F. J. Savelkoul, Roman Grzybowski & Anna Cieślińska. (2020) Single Nucleotide Polymorphisms in 25-Hydroxyvitamin D3 1-Alpha-Hydroxylase (CYP27B1) Gene: The Risk of Malignant Tumors and Other Chronic Diseases. Nutrients 12:3, pages 801.
Crossref
Crossref
Feng Gao & Chun Yang. (2020) Anti-VEGF/VEGFR2 Monoclonal Antibodies and their Combinations with PD-1/PD-L1 Inhibitors in Clinic. Current Cancer Drug Targets 20:1, pages 3-18.
Crossref
Crossref
Jacqueline Wyss, Bastian Dislich, Viktor H. Koelzer, José A. Galván, Heather Dawson, Marion Hädrich, Daniel Inderbitzin, Alessandro Lugli, Inti Zlobec & Martin D. Berger. (2019) Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients. Clinical Colorectal Cancer 18:1, pages e20-e38.
Crossref
Crossref
G. Fornasier, M. Taborelli, S. Francescon, J. Polesel, M. Aliberti, P. De Paoli & P. Baldo. (2018) Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance. International Journal of Clinical Pharmacy 40:4, pages 795-802.
Crossref
Crossref
Martin D. Berger, Sebastian Stintzing, Volker Heinemann, Shu Cao, Dongyun Yang, Yu Sunakawa, Satoshi Matsusaka, Yan Ning, Satoshi Okazaki, Yuji Miyamoto, Mitsukuni Suenaga, Marta Schirripa, Diana L. Hanna, Shivani Soni, Alberto Puccini, Wu Zhang, Chiara Cremolini, Alfredo Falcone, Fotios Loupakis & Heinz-Josef Lenz. (2018) A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab. Clinical Cancer Research 24:4, pages 784-793.
Crossref
Crossref
M.D. Berger, S. Stintzing, V. Heinemann, D. Yang, S. Cao, Y. Sunakawa, Y. Ning, S. Matsusaka, S. Okazaki, Y. Miyamoto, M. Suenaga, M. Schirripa, S. Soni, W. Zhang, A. Falcone, F. Loupakis & H.-J. Lenz. (2017) Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials. Annals of Oncology 28:11, pages 2780-2785.
Crossref
Crossref
Sharon Julie Williams, Amrita Khokhar & Asal Gharib. (2017) Successful rapid desensitization to intravenous bevacizumab using a 14-step protocol: Case report. The Journal of Allergy and Clinical Immunology: In Practice 5:6, pages 1746-1747.
Crossref
Crossref
Gaoxin Lei, Menglong Xu, Zhipan Xu, Lili Gu, Chenchen Lu, Zhengli Bai, Yue Wang, Yongbo Zhang, Huajing Hu, Yiwei Jiang, Wenfeng Zhao & Shuhua Tan. (2017) A Novel Fully Human Agonistic Single Chain Fragment Variable Antibody Targeting Death Receptor 5 with Potent Antitumor Activity In Vitro and In Vivo. International Journal of Molecular Sciences 18:10, pages 2064.
Crossref
Crossref
Ralf-Dieter Hofheinz, Siegfried Segaert, María José Safont, Gaston Demonty & Hans Prenen. (2017) Management of adverse events during treatment of gastrointestinal cancers with epidermal growth factor inhibitors. Critical Reviews in Oncology/Hematology 114, pages 102-113.
Crossref
Crossref
Martin D. Berger, Shinichi Yamauchi, Shu Cao, Diana L. Hanna, Yu Sunakawa, Marta Schirripa, Satoshi Matsusaka, Dongyun Yang, Susan Groshen, Wu Zhang, Yan Ning, Satoshi Okazaki, Yuji Miyamoto, Mitsukuni Suenaga, Sara Lonardi, Chiara Cremolini, Alfredo Falcone, Volker Heinemann, Fotios Loupakis, Sebastian Stintzing & Heinz-Josef Lenz. (2017) Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials. European Journal of Cancer 77, pages 13-20.
Crossref
Crossref
Kyeore Bae, Ji-hye Park, Jeehye Kim, Chong-kwan Cho, Byeongsang Oh, Daniel Costa, Stephanie Lim, Gary Deng & Hwa-Seung Yoo. (2017) Traditional Oriental Herbal Medicine and Natural Killer Cells for Cancer Patients: A Systematic Review and Meta-analysis. Phytotherapy Research 31:4, pages 519-532.
Crossref
Crossref
Slaven Pikija, Georg Pilz, Gerald Gschwandtner, Cornelia Rösler, Konstantin Schlick, Richard Greil & Johann Sellner. (2016) Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device. Frontiers in Neurology 7.
Crossref
Crossref